Novel Lupus Approach Yields Mixed Results in Early Trial

(MedPage Today) -- A drug engineered to "digest" extracellular RNA missed its primary endpoint in an early-stage clinical trial in systemic lupus erythematosus (SLE), though patients with higher disease activity scores did appear to show some improvement...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news